August 28, 2024 at 11:40 am
PRISM Pharma Publication: Atea (AVIR) Publishes Additional Data on Bemnifosbuvir
PRISM Pharma Index company Atea Pharmaceuticals, Inc. (AVIR), a clinical-stage biopharmaceutical company focused on developing oral antiviral treatments for serious viral diseases, announced today the publication of data on the metabolic activation pathway of bemnifosbuvir in the peer-reviewed journal PLOS Biology. The article, titled “The activation cascade of the broad-spectrum antiviral bemnifosbuvir characterized at atomic… [Read More]